Skip to main content

Animations

MJFF Publications

3361 - 3370 of 8808 Results
Title
Year
  • Year
  • 2020
  • 2019
  • 2014
  • 2017
  • 2018
  • 2020
  • 2023
  • 2024
  • 2024
  • 2018
  • Summary Details
    OPEN
    Title: Influence of species and processing parameters on recovery and content of brain tissue‐derived extracellular vesicles
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/20013078.2020.1785746
    Citation Count: 104
  • Summary Details
    OPEN
    Title: Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30285-6
    Citation Count: 460
  • Summary Details
    OPEN
    Title: Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.09.023
    Citation Count: 82
  • Summary Details
    RESTRICTED
    Title: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Minimal Clinically Important Difference for UPDRS‐III in Daily Practice
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12632
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.02.003
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51753
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Exploring the Potential Imaging Biomarkers for Parkinson’s Disease Using Machine Learning Approach
    Journal Name: Bioengineering
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/bioengineering12010011
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Identification and structural characterization of small molecule inhibitors of PINK1
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-58285-3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.010
    Citation Count: 42
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.